#	Pagina
attuale pagina	/open-h2020/projects/198899/index.html

Opendata, web and dolomites

UNIBIO

TK210 ELISA – universal serum protein biomarker for cancer screening, diagnosis, treatment response monitoring and early detection of relapse (UNIBIO)

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

UNIBIO project word cloud

Explore the words cloud of the UNIBIO project. It provides you a very rough idea of what is the project "UNIBIO" about.

blood tissue biomarkers platform amounts tk easily clinical added follow verifying possibility economic unibio feasibility opportunity limits leveraging therapies clinicians diagnosis invasive minimally performed validated treatment procedure monitoring diagnostic serum measured rapid cell deployable protein recognizing cancer abnormal release arocell tumour accuracy validation amount quantifies plasma lies biomarker undergoing business malignancy tk210 cells elisa viability oncologists community thymidine perform efficient utility kinase

Project "UNIBIO" data sheet

The following table provides information about the project.

Coordinator	AROCELL AB (PUBL) Organization address address: VIRDINGS ALLE 32 B city: UPPSALA postcode: 754 50 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Sweden [SE]
Project website	http://www.arocell.com
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SMEINST-1-2015
Funding Scheme	SME-1
Starting year	2015
Duration (year-month-day)	from 2015-09-01 to 2015-10-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	AROCELL AB (PUBL) AROCELL AB (PUBL) Organization address address: VIRDINGS ALLE 32 B city: UPPSALA postcode: 754 50 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	SE (UPPSALA)	coordinator	50˙000.00

Map

Project objective

The UNIBIO project is a feasibility study for TK210 ELISA – a serum and plasma biomarker for cancer diagnosis and treatment response. Leveraging on the knowledge that cancer cells undergoing rapid growth produce and release into the blood abnormal amounts of protein called thymidine kinase (TK), AroCell has pre-validated a biomarker that quantifies the amount of TK protein directly in the serum in a blood sample. Current cell growth-related biomarkers are measured from tumour tissue, which limits their clinical utility. Recognizing a strong business opportunity, AroCell will propose TK210 ELISA as an easily-deployable and cost-efficient diagnostic and treatment-response test. The key need of clinicians and oncologists is the access to reliable biomarkers for the malignancy potential of cancer at diagnosis and effective monitoring of therapies. The test should make it possible to implement cost-efficient added information for diagnosis and follow-up. In the Phase 1 project, AroCell will perform a feasibility study verifying the clinical and economic viability of the clinical validation to be performed in the Phase 2 project. The EU added value of the project lies in the possibility to improve diagnostic accuracy using a minimally invasive diagnostic procedure based on the ELISA platform that is established within the EU Community.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UNIBIO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "UNIBIO" are provided by the European Opendata Portal: CORDIS opendata.